JAGX Jaguar Health Corp Gross Profit Rate

Official company branding of Jaguar Health Inc (JAGX)

Jaguar Health, Inc. (JAGX) develops plant-based treatments to combat diarrhea in HIV and oncology patients, targeting a massive global market. The gross margin variance illustrates sales profitability, while 74.30 shows the current value of the metric. The company's moat is based on patents and the complexity of sourcing raw materials from the jungle. R&D activity is focused on completing Phase 3 trials for crophlemer.

JAGX (jaguar.health) Gross Margin history from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Jaguar Health Corp (JAGX)

- market value and analyst target forecast:
Basic company analysis:Jaguar Animal Health, JAGX
Signature product of Jaguar Animal Health

Gross margin is calculated as the difference between total revenue and the direct cost of goods sold, determining the efficiency of production cost management. An increase in this ratio confirms the high added value of the product and the business model's resilience to costs. For Jaguar Health, Inc. (JAGX), stable sales of its specialized drug offset macroeconomic risks, which is reflected in a steady gross margin structure.